Pramipexole and Selegiline Combination Therapy in a Case of Treatment-Resistant Depression

J Clin Psychopharmacol. 2019 Nov/Dec;39(6):684-685. doi: 10.1097/JCP.0000000000001139.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / pharmacology*
  • Drug Therapy, Combination
  • Humans
  • Male
  • Monoamine Oxidase Inhibitors / administration & dosage
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Pramipexole / administration & dosage
  • Pramipexole / adverse effects
  • Pramipexole / pharmacology*
  • Selegiline / administration & dosage
  • Selegiline / adverse effects
  • Selegiline / pharmacology*

Substances

  • Dopamine Agonists
  • Monoamine Oxidase Inhibitors
  • Selegiline
  • Pramipexole